Home › Cervical Cancer › NCT06128304
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
Who can join
Ages 25 to 64 · Women
Full eligibility criteria
Inclusion Criteria: * Women living with HIV Exclusion Criteria: \-
About the study
While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to leverage the available infrastructure for HIV care and treatment programs in Nigeria to integrate cervical cancer screening and treatment and conduct a cluster randomized, hybrid type III trial design to assess the comparative effectiveness of a Core set of implementation strategies versus a Core+ (enhanced) set of implementation strategies to implement cervical cancer screening, onsite treatment, referral and referral completion, treatment, and retention in care among WLHIV. The overarching goal is to improve the health and life expectancy of WLHIV with co-occurring cervical cancer.
What is being tested
- Core Implementation strategies (other)
- Core+ Enhanced Implementation Strategies (other)
Sponsor: University of California, San Diego · Participants: 2,436 · Started: Nov 13, 2023
Contact the study team
- Gregory Aarons, PhD · Phone: 858-966-7703
- Echezona Ezeanolue, MD, MPH · Phone: +234 803 773 9972
Official record on ClinicalTrials.gov — NCT06128304
Locations in the U.S.
| California | UC San Diego, La Jolla |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.